Tus%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520qd

# Tusqd ## Overview Tusqd is a combination medication containing hydrocodone (an opioid antitussive) and chlorpheniramine (an antihistamine). It is used for the temporary relief of cough and cold symptoms. ## Primary Indications * Temporary relief of cough due to minor throat and bronchial irritation. * Relief of symptoms associated with the common cold, such as runny nose and sneezing. ## Adult Dosing * **Tusqd Syrup:** 5 mL to 10 mL every 4 to 6 hours as needed. Do not exceed 40 mL in 24 hours. * **Tusqd Tablets:** 1 tablet every 4 to 6 hours as needed. ## Pediatric Dosing Safety and efficacy have not been established in pediatric patients under 6 years of age for the syrup formulation. Specific pediatric dosing often depends on age and weight, and should be determined by a healthcare provider based on established guidelines or local protocols. ## Dose Adjustments * **Hepatic Impairment:** Use with caution. Dosage reduction may be necessary. * **Renal Impairment:** Use with caution. Dosage reduction may be necessary. ## Contraindications * Hypersensitivity to hydrocodone or chlorpheniramine. * Acute asthma attack. * Gastrointestinal obstruction. * Concurrent use with MAO inhibitors or within 14 days of discontinuing MAO inhibitors. * Respiratory depression. ## Adverse Effects * **Common:** Drowsiness, dizziness, constipation, nausea, vomiting, dry mouth, blurred vision. * **Serious:** Respiratory depression, CNS depression, confusion, severe constipation, paradoxical excitation (especially in children), hypersensitivity reactions. ## Key Drug Interactions * **CNS Depressants (e.g., alcohol, benzodiazepines, sedatives):** Additive CNS depression. * **MAO Inhibitors:** Risk of hypertensive crisis. * **Serotonergic Drugs:** Increased risk of serotonin syndrome. * **CYP3A4 Inhibitors:** May increase hydrocodone levels, leading to increased opioid adverse effects. ## Monitoring * Monitor for signs of respiratory depression (e.g., slow breathing, shallow breathing). * Assess for CNS effects such as drowsiness or dizziness. * Monitor bowel function for constipation. * Assess for effectiveness of cough suppression. ## Clinical Pearls * Due to the hydrocodone component, Tusqd has a potential for abuse and dependence. * Advise patients to avoid operating heavy machinery or driving until they know how this medication affects them. * This medication can cause significant drowsiness; concurrent use with other sedating agents should be avoided or managed carefully. * Advise patients to avoid alcohol while taking this medication. *** **Disclaimer:** This information is intended for clinical use and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant literature for complete details, including specific indications, contraindications, warnings, precautions, adverse reactions, and drug interactions. Clinical decisions should be based on the individual patient's condition and the judgment of a qualified healthcare professional.